Gut Microbiota Features Associated With Campylobacter Burden and Postnatal Linear Growth Deficits in a Peruvian Birth Cohort.
Campylobacter
child growth
enteropathy
microbiota
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
14 08 2020
14 08 2020
Historique:
received:
16
03
2019
accepted:
13
09
2019
pubmed:
28
11
2019
medline:
28
4
2021
entrez:
28
11
2019
Statut:
ppublish
Résumé
Campylobacter infection is associated with impaired growth of children, even in the absence of symptoms. To examine the underlying mechanisms, we evaluated associations between Campylobacter infection, linear growth, and fecal microbial community features in a prospective birth cohort of 271 children with a high burden of diarrhea and stunting in the Amazonian lowlands of Peru. Campylobacter was identified using a broadly reactive, genus-specific enzyme-linked immunosorbent assay. 16S rRNA-based analyses were used to identify bacterial taxa in fecal samples at ages 6, 12, 18, and 24 months (N = 928). Associations between infection, growth, and gut microbial community composition were investigated using multiple linear regression adjusting for within-child correlations, age, and breastfeeding. Indicator species analyses identified taxa specifically associated with Campylobacter burden. Ninety-three percent (251) of children had Campylobacter present in asymptomatic fecal samples during the follow-up period. A 10% increase in the proportion of stools infected was associated with mean reductions of 0.02 length-for-age z scores (LAZ) at 3, 6, and 9 months thereafter (P < .01). We identified 13 bacterial taxa indicative of cumulative Campylobacter burden and 14 taxa significantly associated with high or low burden of enteroaggregative Escherichia coli, norovirus, or Giardia. Campylobacter infection is common in this cohort and associated with changes in microbial community composition. These results support the notion that disruptions to the fecal microbiota may help explain the observed effects of asymptomatic infections on growth in early life.
Sections du résumé
BACKGROUND
Campylobacter infection is associated with impaired growth of children, even in the absence of symptoms. To examine the underlying mechanisms, we evaluated associations between Campylobacter infection, linear growth, and fecal microbial community features in a prospective birth cohort of 271 children with a high burden of diarrhea and stunting in the Amazonian lowlands of Peru.
METHODS
Campylobacter was identified using a broadly reactive, genus-specific enzyme-linked immunosorbent assay. 16S rRNA-based analyses were used to identify bacterial taxa in fecal samples at ages 6, 12, 18, and 24 months (N = 928). Associations between infection, growth, and gut microbial community composition were investigated using multiple linear regression adjusting for within-child correlations, age, and breastfeeding. Indicator species analyses identified taxa specifically associated with Campylobacter burden.
RESULTS
Ninety-three percent (251) of children had Campylobacter present in asymptomatic fecal samples during the follow-up period. A 10% increase in the proportion of stools infected was associated with mean reductions of 0.02 length-for-age z scores (LAZ) at 3, 6, and 9 months thereafter (P < .01). We identified 13 bacterial taxa indicative of cumulative Campylobacter burden and 14 taxa significantly associated with high or low burden of enteroaggregative Escherichia coli, norovirus, or Giardia.
CONCLUSIONS
Campylobacter infection is common in this cohort and associated with changes in microbial community composition. These results support the notion that disruptions to the fecal microbiota may help explain the observed effects of asymptomatic infections on growth in early life.
Identifiants
pubmed: 31773126
pii: 5571186
doi: 10.1093/cid/ciz906
pmc: PMC7428392
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1000-1007Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK056341
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
EBioMedicine. 2015 Sep 25;2(11):1759-66
pubmed: 26870801
Nutrition. 2009 Mar;25(3):350-8
pubmed: 19036564
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Science. 2016 Feb 19;351(6275):
pubmed: 26912898
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
BMC Gastroenterol. 2013 Mar 08;13:46
pubmed: 23510245
BMJ Open. 2014 Jun 06;4(6):e004816
pubmed: 24907244
Lancet Glob Health. 2018 Mar;6(3):e255-e269
pubmed: 29433665
Am J Trop Med Hyg. 2013 Feb;88(2):390-396
pubmed: 23185075
J Clin Microbiol. 2014 Apr;52(4):1074-80
pubmed: 24452175
JAMA Pediatr. 2017 Jul 1;171(7):647-654
pubmed: 28492938
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S225-32
pubmed: 25305291
PLoS Negl Trop Dis. 2018 Feb 7;12(2):e0006200
pubmed: 29415075
World J Gastroenterol. 2008 Dec 28;14(48):7345-52
pubmed: 19109868
J Pediatr (Rio J). 2018 May - Jun;94(3):258-267
pubmed: 28886400
Pediatr Res. 2015 Jan;77(1-2):229-35
pubmed: 25303277
Front Microbiol. 2017 Mar 06;8:356
pubmed: 28321211
Am J Trop Med Hyg. 2013 Jul;89(1):130-137
pubmed: 23629931
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S248-54
pubmed: 25305294
Front Cell Infect Microbiol. 2015 Feb 05;5:3
pubmed: 25705611
Lancet Glob Health. 2017 Dec;5(12):e1168-e1169
pubmed: 29132605
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Bioinformatics. 2010 Jun 1;26(11):1463-4
pubmed: 20395285
J Clin Microbiol. 2000 Oct;38(10):3853-5
pubmed: 11015419
BMC Gastroenterol. 2014 Nov 18;14:189
pubmed: 25407511
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S220-4
pubmed: 25305290
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S310-6
pubmed: 25305303
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Lancet Glob Health. 2018 Mar;6(3):e302-e315
pubmed: 29396217
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S207-12
pubmed: 25305288
Gut. 2000 Dec;47(6):804-11
pubmed: 11076879
Nat Commun. 2015 Aug 04;6:7806
pubmed: 26241678
J Nutr. 2003 May;133(5):1332-8
pubmed: 12730419
Diagn Microbiol Infect Dis. 2010 Jul;67(3):220-7
pubmed: 20542202
Inflamm Bowel Dis. 2008 Mar;14(3):303-9
pubmed: 18050297
Nature. 2018 Oct;562(7728):583-588
pubmed: 30356187
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S239-47
pubmed: 25305293
Nature. 2014 Jun 19;510(7505):417-21
pubmed: 24896187
J Health Popul Nutr. 2013 Sep;31(3):299-307
pubmed: 24288942
Int J Syst Evol Microbiol. 2011 May;61(Pt 5):1048-1052
pubmed: 20511454
Am J Trop Med Hyg. 2016 Oct 5;95(4):928-937
pubmed: 27503512
Gastroenterology. 2006 Aug;131(2):445-50; quiz 660
pubmed: 16890598
Pediatr Infect Dis J. 2014 Oct;33(10):1004-9
pubmed: 25361185
Clin Infect Dis. 2016 Nov 1;63(9):1171-1179
pubmed: 27501842
Bioinformatics. 2011 Feb 15;27(4):592-3
pubmed: 21169378
PLoS Negl Trop Dis. 2013;7(1):e2036
pubmed: 23383356